Pacira BioSciences, Inc. is a leading provider of non-opioid pain management solutions. The company focuses on developing and commercializing innovative products to improve patient outcomes and reduce reliance on opioids.
EVENTS PER QUARTER · HOVER FOR EMPLOYEE COUNTS
Pacira BioSciences, Inc. has announced layoffs affecting 100 employees as part of its efforts to improve operational efficiency. The decision comes amid a broader trend of job cuts in the industry, but specific details regarding the departments or locations impacted were not disclosed. The layoffs are intended to streamline operations and enhance the company's financial stability. This move reflects ongoing challenges within the biotech sector, where companies are increasingly looking to reduce costs. The layoffs are effective as of October 1, 2023.
Pacira BioSciences, Inc. has announced layoffs affecting 100 employees in its production department located in Parsippany, New Jersey. The layoffs are a result of efforts to improve production efficiencies for Exparel, the company's primary product. This decision comes as part of a broader strategy to streamline operations and reduce costs. The company aims to enhance its operational effectiveness while continuing to focus on delivering quality products to its customers. The layoffs are expected to take effect immediately, impacting the workforce significantly.
No one has shared a story from Pacira BioSciences yet. Went through a layoff here? Your experience helps others feel less alone.
Share your story →We'll email you the moment a new layoff is reported here.